Eminence Capital’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,469,746
| Closed | -$97.3M | – | 64 |
|
|
2022
Q2 | $97.3M | Buy |
2,469,746
+222,278
| +10% | +$8.76M | 1.93% | 22 |
|
|
2022
Q1 | $157M | Sell |
2,247,468
-557
| -0% | -$38.9K | 1.78% | 8 |
|
|
2021
Q4 | $175M | Buy |
2,248,025
+833,812
| +59% | +$64.9M | 1.66% | 11 |
|
|
2021
Q3 | $135M | Buy |
1,414,213
+317,900
| +29% | +$30.3M | 1.82% | 26 |
|
|
2021
Q2 | $136M | Buy |
1,096,313
+346,225
| +46% | +$43M | 1.68% | 27 |
|
|
2021
Q1 | $98.8M | Sell |
750,088
-191,770
| -20% | -$25.3M | 1.22% | 39 |
|
|
2020
Q4 | $125M | Sell |
941,858
-394,897
| -30% | -$52.3M | 1.17% | 31 |
|
|
2020
Q3 | $136M | Buy |
1,336,755
+196,045
| +17% | +$20M | 1.34% | 18 |
|
|
2020
Q2 | $99.2M | Buy |
1,140,710
+802,114
| +237% | +$69.7M | 0.98% | 32 |
|
|
2020
Q1 | $19.6M | Buy |
+338,596
| New | +$19.6M | 0.21% | 90 |
|